Pourhassan, Hoda
Douer, Dan
Pullarkat, Vinod
Aldoss, Ibrahim
Article History
Accepted: 19 September 2022
First Online: 30 November 2022
Declarations
:
: Hoda Pourhassan: none. Dan Douer: Advisory boards for and lecture and research funding from Pfizer, Amgen, Servier, Spectrum, Jazz, Gilead, and Bristol Myers Squibb. Vinod Pullarkat: Advisory board fees and fees for serving on a speaker’s bureau from AbbVie, Genentech, Pfizer, Jazz, Novartis, Servier, and Amgen; consultancy for AbbVie. Ibrahim Aldoss: Advisory boards for Amgen, Kite pharmaceuticals, AbbVie, JAZZ and Agios Pharmaceuticals, and is a consultant for Autolus Therapeutics and Amgen, research support by MacroGenics and Abbvie.